IFIH1 and dermatomyositis: For patients with refractory anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis associated with rapidly progressive interstitial pneumonia, the combination of glucocorticoids and tacrolimus is a potentially effective treatment regimen.